| Literature DB >> 30639829 |
Eftychia Demerouti1, Panagiotis Karyofyllis2, George Athanassopoulos3, George Karatasakis3, Dimitrios Tsiapras3, Athanassios Manginas4, Vasilios Voudris2.
Abstract
Drug-Induced Pulmonary Arterial Hypertension (PAH) represents a well-known entity, predominantly related to anorexigens. Interferon-β (IFN) is considered to be a drug with a possible risk of inducing PAH. We report a patient with Multiple Sclerosis treated with IFN-β who diagnosed with PAH and her course of disease under specific PAH drug therapy. A review of the literature in IFN-β-induced PAH is provided.Entities:
Keywords: Interferon-β; Multiple sclerosis; Pulmonary arterial hypertension
Mesh：
Substances：
Year: 2019 PMID： 30639829 DOI： 10.1016/j.msard.2019.01.018
Source DB: PubMed Journal: Mult Scler Relat Disord ISSN： 2211-0348 Impact factor: 4.339